2019- 2020 - ASD Healthcare › AsdHealthcare › media › ...Fluzone HD and Flublok are returnable up to 20% per presentation. GSK: Fluarix and Flulaval are non-returnable. Product

The ProductsTrivalent Vaccines

Fluad® Seqirus™

PFS

Fluzone® Sanofi Pasteur®

High-Dose PFS

Quadrivalent Vaccines

Afluria® Quadrivalent Seqirus™

MDV, PFS or Pediatric PFS

Fluarix® Quadrivalent GlaxoSmithKline®

PFS

Flublok® Quadrivalent Sanofi Pasteur®

PFS

Flucelvax® Quadrivalent Seqirus™

MDV or PFS

FluLaval® Quadrivalent GlaxoSmithKline®

MDV or PFS

Fluzone® Quadrivalent Sanofi Pasteur®

MDV, SDV, Adult PFS or Pediatric PFS

* Specific pricing and return rights for flu vaccines will be finalized at a later date. All orders for flu vaccines may not be canceled after June 1, 2019 and are automatically considered firm, non-cancellable orders after that date.

Seqirus: Up to 20% per presentation is considered returnable. Sanofi: Up to 20% aggregated Fluzone Quads and Pediatric, excluding Fluzone HD and Flublok. Fluzone HD and Flublok are returnable up to 20% per presentation. GSK: Fluarix and Flulaval are non-returnable. Product may be returned by March 31, 2020. Returns will be applied as a credit toward future purchases.

Customer must provide appropriate licensure for sale and delivery before your order can be shipped. All sales of flu vaccines are subject to the terms and conditions contained in ASD Healthcare’s Customer Application. ASD Healthcare ships flu vaccines based on availability from the manufacturer and will not be held liable for product unavailability, shortages or delays. Product availability is subject to change.

© 2018 ASD Healthcare 1218

The ProgramPriority for Preorders Preorder shipments based on preorder date; the earlier you preorder, the earlier vaccines ship.*

Price Protection Receive our lowest published price from product order date to product shipment date.*

Returnability Return up to 20% of all Sanofi Pasteur and Seqirus Trivalent and Quadrivalent Vaccine orders.

Flexibility Order online, by phone or fax.

Knowledge Regular updates to all customers via email.

GPO Access Contracted GPO members eligible for FluFirst Preorder Program.

FluFirstPREORDER PROGRAM

2019-2020ReStrainPrepare. Provide. Protect against f lu strains.

Preorder online now for 2019-2020

[email protected]@

866.281.4FLU (4358) 800.547.9413

asdhealthcare.com/flu

ASD Healthcare Order Flyer 2019 121918.indd 1 1/16/19 10:16 AM

Arikayce®

Manufactured by Insmed, Inc., Arikayce (amikacin liposome inhalation suspension) is an aminoglycoside antibacterial indicated for use in a limited and specific population of adult patients who have limited or no alternative treatment options for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen and who do not achieve negative sputum cultures after a minimum of six consecutive months of a multidrug background regimen therapy. Arikayce is the first drug to be approved under the Limited Popu-lation Pathway for Antibacterial and Antifungal drugs (LPAD). FDA also granted Fast Track, Breakthrough Therapy, Priority Review and Qualified Infectious Disease Product (QIDP) designations. For specific product ordering information, please see page 22 in our Product Catalog.

Daurismo™Manufactured by Pfizer Inc., Daurismo (glasdegib) is a hedgehog pathway inhibitor indicated for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are 75 years or older or who have comorbidities that preclude use of intensive induction chemotherapy. Daurismo is taken in combination with low-dose cytarabine (LDAC), a type of chemotherapy, and limitation of use may apply. The efficacy of Daurismo was studied in a randomized clinical trial with newly diagnosed AML adult patients. FDA granted Priority Review and Orphan Drug designations. For specific product ordering information, please see page 16 in our Product Catalog.

ASD Healthcare is now an authorized distributor for several new products, which are described

here. We continuously expand our product lines to make sure you have access to the products

you need, when you need them. To verify a product is appropriate to order for your facility, simply

call your sales representative. We’re always here to help you.

Lorbrena®

Manufactured by Pfizer Inc., Lorbrena (lorlatinib), is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on: crizotinib and at least one other ALK inhibitor for metastatic disease; or alectinib as the first ALK inhibitor therapy for metastatic disease; or ceritinib as the first ALK inhibitor therapy for metastatic disease. FDA granted accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.For specific product ordering information, please see page 17 in our Product Catalog.

Lumoxiti™Manufactured by AstraZeneca, Lumoxiti (moxetumomab pasudotox-tdfk) is indicated for the treatment of adult patients with relapsed or refrac-tory hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA). The FDA granted this application Fast Track and Priority Review designa-tions. Lumoxiti also received Orphan Drug designation. A CD22-directed cytotoxin, it is the first of this type of treatment for patients with HCL. For specific product ordering information, please see page 17 in our Product Catalog.

ASD Healthcare | 3

NewProductsAvailable from ASD Healthcare

The ProductsTrivalent Vaccines

Fluad® Seqirus™

PFS

Fluzone® Sanofi Pasteur®

High-Dose PFS

Quadrivalent Vaccines

Afluria® Quadrivalent Seqirus™

MDV, PFS or Pediatric PFS

Fluarix® Quadrivalent GlaxoSmithKline®

PFS

Flublok® Quadrivalent Sanofi Pasteur®

PFS

Flucelvax® Quadrivalent Seqirus™

MDV or PFS

FluLaval® Quadrivalent GlaxoSmithKline®

MDV or PFS

Fluzone® Quadrivalent Sanofi Pasteur®

MDV, SDV, Adult PFS or Pediatric PFS

* Specific pricing and return rights for flu vaccines will be finalized at a later date. All orders for flu vaccines may not be canceled after June 1, 2019 and are automatically considered firm, non-cancellable orders after that date.

Seqirus: Up to 20% per presentation is considered returnable. Sanofi: Up to 20% aggregated Fluzone Quads and Pediatric, excluding Fluzone HD and Flublok. Fluzone HD and Flublok are returnable up to 20% per presentation. GSK: Fluarix and Flulaval are non-returnable. Product may be returned by March 31, 2020. Returns will be applied as a credit toward future purchases.

Customer must provide appropriate licensure for sale and delivery before your order can be shipped. All sales of flu vaccines are subject to the terms and conditions contained in ASD Healthcare’s Customer Application. ASD Healthcare ships flu vaccines based on availability from the manufacturer and will not be held liable for product unavailability, shortages or delays. Product availability is subject to change.

© 2018 ASD Healthcare 1218

The ProgramPriority for Preorders Preorder shipments based on preorder date; the earlier you preorder, the earlier vaccines ship.*

Price Protection Receive our lowest published price from product order date to product shipment date.*

Returnability Return up to 20% of all Sanofi Pasteur and Seqirus Trivalent and Quadrivalent Vaccine orders.

Flexibility Order online, by phone or fax.

Knowledge Regular updates to all customers via email.

GPO Access Contracted GPO members eligible for FluFirst Preorder Program.

FluFirstPREORDER PROGRAM

2019-2020ReStrainPrepare. Provide. Protect against f lu strains.

Preorder online now for 2019-2020

[email protected]@

866.281.4FLU (4358) 800.547.9413

asdhealthcare.com/flu

ASD Healthcare Order Flyer 2019 121918.indd 1 1/16/19 10:16 AM

Marqibo®

Manufactured by Spectrum Pharmaceuticals, Marqibo (vinCRIStine sul-fate LIPOSOME injection) is indicated for the treatment of adult patients diagnosed with Philadelphia chromosome-negative (PH-) acute lympho-blastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies. This indication is based on overall response rate. Clinical benefit such as improvement in the overall survival has not been verified. For specific product ordering information, please see page 17 in our Product Catalog.

Talzenna®

Manufactured by Pfizer Inc., Talzenna (talazoparib) capsule is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) HER2-negative locally advanced or metastatic breast cancer. Approval was based on results from the EMBRACA trial. FDA also granted Priority Review for this application. Eligibility for therapy with Talzenna should be considered based on an FDA-approved companion diagnostic, BRACAnalysis CDx test, by Miriad Genetic Laboratories, Inc.For specific product ordering information, please see page 18 in our Product Catalog.

Tegsedi™Manufactured by Akcea Therapeutics, Tegsedi (inotersen) injection is indicated for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. This is the first and only subcutaneous RNA-targeting drug designed to reduce the production of TTR protein.

FDA approval is based on data from the NEURO-TTR study which demon-strated significant benefit compared to placebo measures.For specific product ordering information, please see page 24 in our Product Catalog.

Vitrakvi®Manufactured by Bayer, Vitrakvi (larotrectinib) is indicated for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity and have no satisfactory alternative treatments or that have progressed following treatment. FDA granted accelerated approval based on efficacy studied in three clinical trials that included pediatric and adult patients. The FDA also granted this application Priority Review, Breakthrough Therapy and Orphan Drug designations. For specific product ordering information, please see page 19 in our Product Catalog.

Xospata®

Manufactured by Astellas Pharma US, Inc., Xospata (gilteritinib) tablets is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 muta-tion as detected by an FDA-approved test. The FDA granted this applica-tion Fast Track and Priority Review designations. Xospata also received Orphan Drug designation. For specific product ordering information, please see page 19 in our Product Catalog.

4 | I ns ideOut

NewProducts

ASD Healthcare | 5

NewIndicationsFDA approved

Adcetris®Adcetris (brentuximab vedotin), manufactured by Seattle Genetics, Inc., recently gained FDA approval in combination with CHP chemotherapy (cyclophosphamide, doxorubicin, prednisone) for the treatment of adults with previously untreated systemic anaplastic large cell lymphoma (sALCL) or other CD30-expressing peripheral T-cell lymphomas (PTCL), including angioimmunoblastic T-cell lymphoma and PTCL not otherwise specified. Approval was granted based on the successful outcome of the Phase 3 ECHELON-2 clinical trial that compared Adcetris plus CHP to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). The FDA granted Breakthrough Therapy designation and Priority Review, reviewing it under the Real-Time Oncology Review Pilot Program which lead to approval in less than two weeks after submission of the complete application. This is the sixth FDA-approved indication for Adcetris. For a listing of all FDA approved indications, please refer to the prescribing information (PI) or visit fda.gov.For specific product ordering information, please see page 15 in our Product Catalog.

Empliciti®Bristol-Myers Squibbs’ Empliciti (elotuzumab) was recently granted Priority Review and approval by the FDA for use in combination with pomalidomide and dexamethasone (EPd) for the treatment of adult patients with multiple myeloma who have received at least two prior therapies, including lenalido-

mide and a proteasome inhibitor. Approval was based on ELOQUENT-3, an open-label, Phase 2 study. Empliciti is already approved in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies.For specific product ordering information, please see page 16 in our Product Catalog.

Keytruda®

FDA has approved Keytruda (pembrolizumab), manufactured by Merck, for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. This indication received accelerated approval based on tumor response rate and durability of response data obtained from the KEYNOTE-224 trial. Continued approval may be contingent upon verification and description of clinical benefit in the confirmatory trials.

In addition, Keytruda was also recently approved in combination with carboplatin and either paclitaxel or nab-paclitaxel for the first-line treat-ment of patients with metastatic squamous non-small cell lung cancer (NSCLC) based on results from the KEYNOTE-407 trial.

For a listing of all FDA approved indications, please refer to the prescribing information (PI) or visit fda.gov.For specific product ordering information, please see page 17 in our Product Catalog.

6 | I ns ideOut

NewIndicationsFind product ordering information on all

ASD Healthcare products in our Product

Catalog on page 7.

Get recent updates to new products and

new indications at www.asdhealthcare.com/

products/new-products.

Promacta®

Manufactured by Novartis, Promacta (eltrombopag) recently received FDA approval for an expanded label to include first-line treatment for adults and pediatric patients, two years and older, with severe aplastic anemia (SAA) in combination with standard immunosuppressive therapy (IST). The FDA also granted Promacta Breakthrough Therapy designation as a counter measure for hematopoietic sub-syndrome of acute radiation syndrome (H-ARS). Promacta is already approved for SAA for patients who had an insufficient response to IST, as well as for adults and children with chronic immune thrombocytopenia (ITP) who are refractory to other treatments, and for the treatment of thrombocytopenia is patients with chronic hepatitis C virus (HCV) infection. For specific product ordering information, please see page 22 in our Product Catalog.

Tecentriq™FDA has approved Tecentriq (atezolizumab), manufactured by Genentech, in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous, non-small cell lung cancer (NSq NSCLC) with no EFGR or ALK genomic tumor aberrations. First granted priority review, approval was based on the IMpower 150 trial – an open-label, randomized, three-arm trial that enrolled 1,202 patients receiving first-line treatment for metastatic NSq NSCLC. Major efficacy measures included overall survival and progression-free survival. Tecentriq is a programmed death-ligand 1 (PD-L1) blocking antibody and was already indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma. For specific product ordering information, please see page 18 in our Product Catalog.

Venclexta®FDA has granted accelerated approval of Genentech’s Venclexta (vene-toclax), in combination with a hypomethylating agent (azacitidine or decitabine) or low-dose cytarabine (LDAC), for the treatment of people with newly-diagnosed acute myeloid leukemia (AML), who are age 75 years or older, or for those ineligible for intensive induction chemotherapy due to coexisting medical conditions. AML is the most common type of aggres-sive leukemia in adults and has the lowest survival rate for all types of leukemia. Accelerated approval was based on results from the M14-358 and M14-387 studies.For specific product ordering information, please see page 19 in our Product Catalog.

ProductCatalogOur most popular products

ASD Healthcare | 7

Consumer Products Showcase Check out Consumer Products available through ABC Order or ABC Passport ordering system!

Showcased products represent just a few of the extensive line of consumer products available from AmerisourceBergen. AmerisourceBergen works with more than 600 manufacturers in areas of CPG, OTC products, diabetes and home healthcare, so you may easily order just about any consumer products for your pharmacy.

In addition, AmerisourceBergen carries advanced wound, institutional diabetes, ostomy/catheter items, gravity sets, clean room and store supplies.

Not an AmerisourceBergen customer?

610.727.7000 or [email protected]

PD Plasma DerivativesAlbumin 8 Antihemophilic 9 Immunologic 10 Hyper-Immune Globulin 14

O OncologyOncology/Supportive Care 15

P PharmaceuticalsVaccines 21 Specialty 22 Biosurgery 25

CM Contrast MediaBracco 26

N NephrologyNephrology Rx 27 Medical / Surgical 32

Our ASD Healthcare Product Catalog

is your convenient way to get quick

updates for our most popular products,

including oncology, plasma derivatives,

pharmaceuticals, contrast media and

nephrology.

If you don’t see a product you need, just call 800.746.6273 for personalized service. We have thousands of additional choices to complete your order.

Plasma DerivativesPDAlbuminCODE PRODUCT SIZE EQ. UNIT MFR. NDC # PK/CS

P9045 Albuked™ 5% 250 mL 1 KED 76125-0790-25 vl

P9047 Albuked™ 25% 50 mL KED 76125-0792-25 vl

P9047 Albuked™ 25% 100 mL KED 76125-0792-10 vl

P9045 Albumin 5% 250 mL 1 OCT 68982-0623-02 vl




P9047 Albuminar® 25% 50 mL 1 CSL 00053-7680-32 vl

P9047 Albuminar® 25% 100 mL CSL 00053-7680-33 vl

P9041 Albutein® 5% (Albumin) 50 mL 0.5 GFS 68516-5214-05 vl

P9045 Albutein® 5% (Albumin) 250 mL 1 GFS 68516-5214-01 vl


P9046 Albutein® 25% (Albumin) 20 mL 0.4 GFS 68516-5216-05 vl



P9047 AlbuRx® 25% 50 mL 1 CSL 44206-0251-05 vl

P9047 AlbuRx® 25% 100 mL 2 CSL 44206-0251-10 vl

P9045 AlbuRx® 5% 250 mL 1 CSL 44206-0310-25 vl

P9045 AlbuRx® 5% 500 mL 2 CSL 44206-0310-50 vl

P9045 Flexbumin 5% 10 x 250 mL 1 BXLT 00944-0495-05 cs



8 | I ns ideOut

Go to www.asdhealthcare.com for pricing, ordering and more.Product availability subject to change.

AntihemophilicCODE PRODUCT SIZE MFR. NDC # PK/CS

Factor VIIa (Recombinant)

J7189 NovoSeven® RT with MixPro® 1 mg NOVO 00169-7201-01 vl




Factor VIII (Recombinant)

J7192 Advate® w/Baxject III 250 iu BXLT 00944-3051-02 vl







J7207 Adynovate 250 iu BXLT 00944-4622-01 vl







J7210 AFSTYLA® 250 iu CSL 69911-0474-02 vl







J7205 Eloctate® Kit 250 iu BIOV 71104-0801-01 vl










ASD Healthcare | 9

Plasma DerivativesPDCODE PRODUCT SIZE MFR. NDC # PK/CS

J7199 Jivi® 500 iu BYR 00026-3942-25 vl

J7199 Jivi® 1000 iu BYR 00026-3944-25 vl

J7199 Jivi® 2000 iu BYR 00026-3946-25 vl

J7199 Jivi® 3000 iu BYR 00026-3948-25 vl

J7192 Kogenate® FS Adaptor PDS 250 iu BYR 00026-3782-25 vl





J7211 Kovaltry® w/ Vial Adapter 250 iu BYR 00026-3821-25 vl





J7182 Novoeight® 250 iu NOVO 00169-7825-01 vl






J7209 Nuwiq® 250 iu LFP vl kit OCT 68982-0139-01 ea




J7209 Nuwiq® 3000 iu LFP vial kit OCT 68982-0149-01 ea


J7192 Recombinate® PDS 250 iu/5 mL vl BXLT 00944-2841-10 vl





J7185 Xyntha® Kit KS 250 iu PFZ 58394-0012-01 vl

J7185 Xyntha® PDS Kit 500 iu PFZ 58394-0013-01 vl

J7185 Xyntha® PDS Kit 1000 iu PFZ 58394-0014-01 vl

J7185 Xyntha® Kit KS 2000 iu PFZ 58394-0015-01 vl

J7185 Xyntha® PDS Solofuse SYR 250 iu PFZ 58394-0022-03 ea





Factor VIII (Immunoaffinity Purified. Derived from Human Plasma.)

J7190 Hemofil® M PDS AHF 250 iu BXLT 00944-3940-02 vl




10 | I ns ideOut


NEW

CODE PRODUCT SIZE MFR. NDC # PK/CS

Factor VIII (Derived from Human Plasma. Contains von Willebrand Factor.)

J7186 Alphanate® AHF 250 iu GFS 68516-4611-01 vl





J7187 Humate-P® PDS RCoF 500 iu RCoF CSL 63833-0615-02 vl



J7183 Wilate® PDS VW Kit 500 iu RCo/5 mL OCT 68982-0182-01 pds vw kit

J7183 Wilate® PDS VW Kit 1000 iu RCo/10 mL OCT 68982-0182-02 pds vw kit

Factor IX (Recombinant)

J7201 Alprolix® Kit 250 iu BIOV 71104-0966-01 vl






J7195 BeneFIX®-RT PDS 250 iu PFZ 58394-0633-03 vl





J7202 Idelvion® 250 iu SDV CSL 69911-0864-02 vl





J7195 Rebinyn® 500 iu NOVO 00169-7905-01 vl



J7200 RIXUBIS Kit BAXJECT 250 iu BXLT 00944-3026-02 vl




J7200 RIXUBIS KIT BAXJECT 3000 iu BXLT 00944-3034-02 vl

Factor IX (Prothrombin Concentrates. Derived from Human Plasma. Contains Factor II, VII, IX and X.)

C9132 Kcentra® 500 iu SDV CSL 63833-0386-02 vl


J7194 Profilnine® SD PDS 500 iu GFS 68516-3207-01 vl



ASD Healthcare | 11


Factor IX (Derived from Human Plasma)

J7193 AlphaNine® SD PDS 500 iu GFS 68516-3607-02 vl



J7193 Mononine® PDS 1000 iu CSL 00053-6233-02 vl

Factor XIII (Derived from Human Plasma)

J7180 Corifact® PDS 1000 - 1600 iu CSL 63833-0518-02 vl

Factor Xa (Recombinant)

Andexxa® 4 x 100 mg PORT 69853-0101-01 vl

Fibrinogen Concentrate

J1680 RiaSTAP™ 1000 mg CSL 63833-0891-51 vl

Anti-Inhibitor Coagulation Complexes (Derived from Human Plasma)

J7198 Feiba® NF PDS 500 iu BXLT 64193-0426-02 vl



Antithrombin III (Derived from Human Plasma)

J7197 Thrombate III® PDS 500 iu GFS 13533-0602-50 vl

Desmopressin Acetate (Useful in Disorders of Hemostasis)

J2597 Stimate® (Nasal Spray) 1.5 mg SPY 2.5 mL CSL 00053-6871-00 ea

Recombinate von Willebrand Factor

J7179 Vonvendi® 500 iu/5 mL vl BXLT 00944-7551-02 vl

J7179 Vonvendi® 1500 iu/10 mL vl BXLT 00944-7553-02 vl

ImmunologicCODE PRODUCT SIZE MFR. NDC # PK/CS

Immune Globulin Intravenous (Human) Lyophilized

J1566 Gammagard® 5% S/D Low IgA 5 gm BXLT 00944-2656-03 vl

J1566 Gammagard® 5% S/D Low IgA 10 gm BXLT 00944-2658-04 vl

Immune Globulin Intravenous (Human) Liquid

J1572 Flebogamma® DIF 5% 2.5 gm GFS 61953-0004-02 vl

J1572 Flebogamma® DIF 5% 5 gm GFS 61953-0004-03 vl






J1569 Gammagard® 10% Liquid 1 gm BXLT 00944-2700-02 vl

J1569 Gammagard® 10% Liquid 2.5 gm BXLT 00944-2700-03 vl



12 | I ns ideOut





J1561 Gammaked™ 10% 1 gm KED 76125-0900-01 vl




J1557 Gammaplex® 5% 5 gm BPL 64208-8234-06 vl






J1561 Gamunex® -C 1 gm GFS 13533-0800-12 vl

J1561 Gamunex® -C 2.5 gm GFS 13533-0800-15 vl





J1568 Octagam® 5% 1 gm OCT 68982-0840-01 vl

J1568 Octagam® 5% 2.5 gm OCT 68982-0840-02 vl







Panzyga 10% 1 gm/10 mL OCT 68982-0820-01 vl

Panzyga 10% 2.5 gm/25 mL OCT 68982-0820-02 vl





J1459 Privigen® 10% 5 gm CSL 44206-0436-05 vl




Immune Globulin Subcutaneous (Human) Liquid

J1559 Hizentra® 1 gm CSL 44206-0451-01 vl




J1575 HyQvia® 10% Liquid 2.5 gm BXLT 00944-2510-02 vl

J1575 HyQvia® 10% Liquid 5 gm BXLT 00944-2511-02 vl

NEW

NEW

NEW

NEW

NEW

NEW

ASD Healthcare | 13





Hyper-Immune GlobulinCODE PRODUCT SIZE MFR. NDC # PK/CS

Intramuscular Immune Globulins (Human)

J1460 GamaSTAN® S/D 2 mL GFS 13533-0335-04 vl

J1560 GamaSTAN® S/D 10 mL GFS 13533-0335-12 vl

CPT-90396 Varizig® Liquid 125 iu SAOL 70504-0126-02 vl

Rho(D) Immune Globulin

J2788 HyperRHO® S/D Mini-Dose 250 iu GFS 13533-0661-06 10/pk

J2790 HyperRHO® S/D 1500 iu GFS 13533-0631-02 syr

J2790 HyperRHO® S/D 1500 iu GFS 13533-0631-11 10/pk

J2788 MICRhoGAM® UF Plus 1 x 50 mcg KED 00562-7806-01 syr

J2788 MICRhoGAM® UF Plus 5 x 50 mcg KED 00562-7806-05 5/pk

J2788 MICRhoGAM® UF Plus 25 x 50 mcg KED 00562-7806-25 25/pk

J2790 RhoGAM® UF Plus 1 x 300 ug KED 00562-7805-01 syr

J2790 RhoGAM® UF Plus 5 x 300 ug KED 00562-7805-05 5/pk

J2790 RhoGAM® UF Plus 25 x 300 ug KED 00562-7805-25 25/pk

J2791 Rhophylac® 300 mcg CSL 44206-0300-01 syr

J2791 Rhophylac® 300 mcg CSL 44206-0300-10 10/pk

J2792 WinRho® SDF Liquid 1500 iu 300 mcg APVO 70504-3300-02 vl




Hepatitis B Immune Globulin

J1573/J1571 HepaGam B® 1 mL APVO 70504-0052-02 vl

J1573/J1571 HepaGam B® 5 mL APVO 53270-0051-01 vl

J1573/J1571 HepaGam B® NovaPlus 5 mL APVO 53270-0054-01 vl

CPT 90371 HyperHEP B® S/D 0.5 mL GFS 13533-0636-03 syr

CPT 90371 HyperHEP B® S/D 1 mL GFS 13533-0636-02 syr

CPT 90371 HyperHEP B® S/D 5 mL GFS 13533-0636-05 vl

CPT 90371 Nabi-HB® 1 mL BIOT 59730-4202-01 vl

CPT 90371 Nabi-HB® 5 mL BIOT 59730-4203-01 vl

Rabies Immune Globulin

CPT 90375 HyperRAB® 300 iu/mL 1 mL GFS 13533-0318-01 vl

CPT 90375 HyperRAB® 300 iu/mL 5 mL GFS 13533-0318-05 vl

CPT 90399 KedRAB™ 2 mL KED 76125-0150-02 vl

CPT 90399 KedRAB™ 10 mL KED 76125-0150-10 vl

Tetanus Immune Globulin

J1670 HyperTET® S/D 1 mL GFS 13533-0634-02 syr

Cytomegalovirus Immune Globulin Intravenous (Human)

J0850 CytoGam® 2.5 gm/50 mL CSL 44206-0532-11 vl

14 | I ns ideOut


J9042 Adcetris® 50 mg SGEN 51144-0050-01 vl

J7527 Afinitor® 2.5 mg/28 tabs NOV 00078-0594-51 pk

J7527 Afinitor® 5 mg/28 tabs NOV 00078-0566-51 pk

J7527 Afinitor® 7.5 mg/28 tabs NOV 00078-0620-51 pk

J7527 Afinitor® 10 mg/28 tabs NOV 00078-0567-51 pk

J7527 Afinitor Disperz® 2 mg/28 tabs NOV 00078-0626-51 pk



Alecensa® 150 mg/240 caps GNT 50242-0130-01 ea

J9305 Alimta® 100 mg inj ELI 00002-7640-01 vl

J9305 Alimta® 500 mg inj ELI 00002-7623-01 vl

Aliqopa™ 60 mg SDV BYR 50419-0385-01 vl

J2469 Aloxi® 0.25 mg/5 mL SDV EISAI 62856-0797-01 vl

Alunbrig™ 90 mg/7 tabs MILL 63020-0090-07 pk




Alunbrig™ 90/180 mg tabs copack MILL 63020-0198-30 pk

J9035 Avastin® 100 mg GNT 50242-0060-01 vl

J9035 Avastin® 400 mg GNT 50242-0061-01 vl

J9025 Azacitidine 100 mg generic* vl

Bavencio® 200 mg/10 mL EMD 44087-3535-01 vl

J9032 Beleodaq® 500 mg/30 mL LYO SDV SPEC 68152-0108-09 vl

Besponsa® 0.9 mg SDV PF 20 mL PFZ 00008-0100-01 vl

J9039 Blincyto® 35 mcg SDV AMG 55513-0160-01 vl

Bosulif® 100 mg/120 tabs PFZ 00069-0135-01 pk

Bosulif® 400 mg/tab 30 PFZ 00069-0193-01 pk

Bosulif® 500 mg/30 tabs PFZ 00069-0136-01 pk

Braftovi™ 50 mg 2 x 60 cap ARRAY 70255-0020-01 btl

Braftovi™ 75 mg 2 x 90 cap ARRAY 70255-0025-01 btl

J8999 Cabometyx™ 20 mg/30 tabs EXEL 42388-0024-26 ea



Calquence® 100 mg cap 60 ASTRA 00310-0512-60 ea

Copiktra 15 mg/56 caps VERA 71779-0115-02 pk

Copiktra 25 mg/56 caps VERA 71779-0125-02 pk

J9120 Cosmegen® Injectable 0.5 mg REC 55292-0811-55 vl

J8999 Cotellic™ 20 mg/63 tabs GNT 50242-0717-01 ea

J9308 Cyramza® 100 mg/10 mL SDV ELI 00002-7669-01 vl

J9308 Cyramza® 500 mg/50 mL SDV ELI 00002-7678-01 vl

* This generic product may be available from multiple manufacturers, depending on inventory availibility.

OncologyO

ASD Healthcare | 15

OncologyOCODE PRODUCT SIZE MFR. NDC # PK/CS

J0894 Dacogen® 50 mg SDV OTS 59148-0046-70 ea

J9145 Darzalex™ 100 mg/5 mL SDV SOL JOM 57894-0502-05 ea

J9145 Darzalex™ 400 mg/20 mL SDV SOL JOM 57894-0502-20 ea

Daurismo™ 25 mg/60 tabs PFZ 00069-0298-60 btl

Daurismo™ 100 mg/30 tabs PFZ 00069-1531-30 btl

J9176 Empliciti™ 300 mg SDV LYO BMS 00003-2291-11 ea

J9176 Empliciti™ 400 mg SDV LYO BMS 00003-4522-11 ea

J9055 Erbitux® 100 mg/50 mL ELI 66733-0948-23 vl

J9055 Erbitux® 200 mg/100 mL ELI 66733-0958-23 vl

Erivedge® 150 mg/28 caps GNT 50242-0140-01 ea

Erleada™ 60 mg tab 120 JOM 59676-0600-12 btl

Farydak® 10 mg cap 6 UD NOV 00078-0650-06 pk



J9395 Faslodex® 500 mg PF syr 2 x 5.0 mL AZP 00310-0720-10 pk

J9307 Folotyn™ 20 mg ALLOS 48818-0001-01 vl

J9307 Folotyn™ 40 mg ALLOS 48818-0001-02 vl

J0641 Fusilev® (Levoleucovorin) Injectable 50 mg SPEC 68152-0101-00 vl

J9301 Gazyva® 1000 mg/40 mL GNT 50242-0070-01 ea

J8999 Gilotrif® 20 mg/30 tabs BIP 00597-0141-30 pk



J9179 Halaven® 1 mg/2 mL SDV EISAI 62856-0389-01 vl

J9355 Herceptin® 150 mg SDV GNT 50242-0132-01 ea

J8999 Ibrance® 75 mg/21 caps PFZ 00069-0187-21 ea



IDHIFA® 50 mg/30 tabs CEL 59572-0705-30 ea

IDHIFA® 100 mg/30 tabs CEL 59572-0710-30 ea

J8999 Imbruvica® 70 mg/28 caps PHA 57962-0070-28 btl



J8999 Imbruvica® 140 mg tab 28 UD PHA 57962-0014-28 pk




J9173 Imfinzi™ 120 mg SDV AZP 00310-4500-12 vl

J9173 Imfinzi™ 500 mg SDV AZP 00310-4611-50 vl

J9325 Imlygic® 106 1 m PFU/mL 1 mL vl AMG 55513-0078-01 vl

J9325 Imlygic® 108 100 m PFU/mL 1 mL vl AMG 55513-0079-01 vl

J8999 Inlyta® 1 mg tab 180 PFZ 00069-0145-01 pk

J8999 Inlyta® 5 mg tab 60 PFZ 00069-0151-11 pk

J8565 Iressa® 250 mg/30 tabs AZP 00310-0482-30 btl

J9315 Istodax® 10 mg Injection SOL Kit CEL 59572-0984-01 vl

NEW

NEW

16 | I ns ideOut



J9207 Ixempra® 15 mg RPHRM 70020-1910-01 ea

J9207 Ixempra® 45 mg RPHRM 70020-1911-01 ea

J8999 Jakafi® 5 mg/60 tabs INCY 50881-0005-60 ea





J9354 Kadcyla® 100 mg/15 mL SDV GNT 50242-0088-01 vl

J9354 Kadcyla® 160 mg/20 mL SDV GNT 50242-0087-01 vl

J9271 Keytruda® 100 mg/4mL SDV SOL MERCK 00006-3026-02 ea

J9285 Lartruvo™ 190 mg/19 mL SDV SOL ELI 00002-7190-01 ea

J9285 Lartruvo™ 500 mg/50 mL SDV SOL ELI 00002-8926-01 ea

J8998 Lenvima® 4 mg cap 30 UD EISAI 62856-0704-30 pk





J8999 Lenvima® 10 mg/4 mg 14 mg DD 30 UD EISAI 62856-0714-30 pk



Libtayo 350 mg/7 mL SDV REG 61755-0008-01 vl

J8999 Lonsurf® 15 mg/20 tabs TAIHO 64842-1025-01 btl






Lorbrena® 25 mg/30 tabs PFZ 00069-0227-01 btl

Lorbrena® 100 mg/30 tabs PFZ 00069-0231-01 btl

Lumoxiti™ 1 mg LYO SDV AZP 00310-4700-01 vl

Lumoxiti™ 1 mg IVSS SDV AZP 00310-4715-11 vl

Lynparza™ 50 mg caps 4 x 112 carton AZP 00310-0657-58 pk

Lynparza™ 100 mg tab 60 AZP 00310-0668-60 pk




Marqibo® 5 mg/31 mL Kit SPEC 20536-0322-01 ea

J8999 Mekinist™ 0.5 mg/30 tabs NOV 00078-0666-15 ea

J8999 Mekinist™ 2 mg/30 tabs NOV 00078-0668-15 ea

Mektovi® 15 mg tab 180 ARRAY 70255-0010-02 ea

J9203 Mylotarg™ 4.5 mg SDV PFZ 00008-4510-01 vl

Nerlynx® 40 mg tab 180 PUMA 70437-0240-18 btl

J2505 Neulasta® Onpro™ syringe 6 mg/0.6 mL AMG 55513-0190-01 syr

J2505 Neulasta® Onpro™ Kit 6 mg/0.6 mL AMG 55513-0192-01 syr

J8999 Nexavar® 200 mg/120 tabs BYR 50419-0488-58 btl

NEW

NEW

NEW

NEW

NEW

ASD Healthcare | 17

OncologyO

NEW

NEW

18 | I ns ideOut


J8999 Ninlaro® 2.3 mg caps 3/pk MILL 63020-0078-02 pk

J8999 Ninlaro® 3 mg caps 3/pk MILL 63020-0079-02 pk

J8999 Ninlaro® 4 mg caps 3/pk MILL 63020-0080-02 pk

J2796 Nplate® 250 mcg SDV 0.5 mL AMG 55513-0221-01 vl

J2796 Nplate® 500 mcg SDV 1.0 mL AMG 55513-0222-01 vl

J8999 Odomzo® 200 mg/30 caps SUN 47335-0303-83 btl

J9266 Oncaspar® 750 iu/mL SDV 5 mL BXLT 00944-3810-01 vl

J9205 Onivyde® 43 mg/10 mL SDV SOL IPSN 15054-0043-01 vl

J9299 Opdivo® 40 mg/4 mL BMS 00003-3772-11 vl



J9306 Perjeta® 420 mg/14 mL SDV GNT 50242-0145-01 vl

J9295 Portrazza® 800 mg / 50 mL SDV SOL ELI 00002-7716-01 vl

Q2043 Provenge® 250 mL VAL 30237-8900-06 vl

J9310 Rituxan® 100 mg/10 mL GNT 50242-0051-21 vl

J9310 Rituxan® 500 mg/50 mL GNT 50242-0053-06 vl

Rituxan® Hycela 1400 mg SDV GNT 50242-0108-01 vl

Rituxan® Hycela 1600 mg SDV GNT 50242-0109-01 vl

J8999 Rubraca™ 200 mg/60 tabs CLVS 69660-0201-91 btl



J1300 Soliris® 300 mg/30 mL ALX 25682-0001-01 vl

J8999 Stivarga® 40 mg tabs BYR 50419-0171-03 btl

J1627 Sustol® 10 mg/0.4 mL PFS kit 6/pk HRTX 47426-0101-06 pk

J8999 Sutent® 12.5 mg/28 caps PFZ 00069-0550-38 btl

J8999 Sutent® 25 mg/28 caps PFZ 00069-0770-38 btl

J8999 Sutent® 37.5 mg/28 caps PFZ 00069-0830-38 btl

J8999 Sutent® 50 mg/28 caps PFZ 00069-0980-38 btl

J8999 Tafinlar® 50 mg/120 caps NOV 00078-0682-66 ea

J8999 Tafinlar® 75 mg/120 caps NOV 00078-0681-66 ea

J8999 Tagrisso™ 40 mg/30 tabs AZP 00310-1349-30 ea

J8999 Tagrisso™ 80 mg/30 tabs AZP 00310-1350-30 ea

Talzenna® 0.25 mg/30 caps PFZ 00069-0296-30 btl

Talzenna® 1 mg/30 caps PFZ 00069-1195-30 btl

J8999 Tarceva® 25 mg/30 tabs GNT 50242-0062-01 btl



J3590 Targretin® 1% gel 60 gm VAL 00187-5525-60 ea

J8999 Targretin® 75 mg SGC 100 VAL 00187-5526-75 ea

J8999 Tasigna® 50 mg/120 caps NOV 00078-0951-66 ea

J8999 Tasigna® 150 mg/28 caps NOV 00078-0592-87 bx

J8999 Tasigna® 200 mg/28 caps NOV 00078-0526-87 bx

J9999 Tecentriq™ 1200 mg/20 mL SDV GNT 50242-0917-01 vl


NEW

NEW

NEW

NEW


Tibsovo® 250 mg/60 tabs AGI 71334-0100-01 btl

J1190 Totect® 500 mg SDV CBL 66220-0110-01 vl

J9033 Treanda® 25 mg/8 mL TEVA 63459-0390-08 vl

J9033 Treanda® 100 mg/20 mL TEVA 63459-0391-20 vl

J8999 Tykerb® 250 mg/150 tabs NOV 00078-0671-19 ea

J9999 Unituxin® 17.5 mg/5 mL SDV UNT 66302-0014-01 vl

J8499 Venclexta™ 1 x 50 mg tab UD ABBV 00074-0566-11 ea

J8499 Venclexta™ 1 x 100 mg tab UD ABBV 00074-0576-11 ea

J8499 Venclexta™ 2 X 10 mg tab UD ABBV 00074-0561-11 ea

J8499 Venclexta™ 7 X 50 mg tab wallet ABBV 00074-0566-07 ea

J8499 Venclexta™ 14 X 10 mg tab wallet ABBV 00074-0561-14 ea

J8499 Venclexta™ 100 mg/120 tabs ABBV 00074-0576-22 ea

J8499 Venclexta™ Starter Pack ABBV 00074-0579-28 pk

J9025 Vidaza® 100 mg CEL 59572-0102-01 vl

Vitrakvi® 25 mg cap 60 BYR 71777-0390-01 btl

Vitrakvi® 100 mg cap 60 BYR 71777-0391-01 btl

Vitrakvi®20 mg/mL 100 mL SOL (Pediatric Formulation)

BYR 71777-0392-01 vl

Vizimpro® 15 mg tab 30 PFZ 00069-0197-30 btl



J8999 Votrient® 200 mg/120 tabs NOV 00078-0670-66 ea

J8999 Xalkori® 200 mg cap 60 PFZ 00069-8141-20 btl

J8999 Xalkori® 250 mg cap 60 PFZ 00069-8140-20 btl

Xospata® 40 mg tab 90 AST 00469-1425-90 btl

J8999 Xtandi® 40 mg cap 120 AST 00469-0125-99 ea

J9228 Yervoy® 50 mg/10 mL BMS 00003-2327-11 vl

J9228 Yervoy® 200 mg/40 mL BMS 00003-2328-22 vl

J9352 Yondelis® 1 mg PWD SDV JOM 59676-0610-01 ea

Yonsa® 125 mg tabs 120 SUN 47335-0401-81 ea

J9400 Zaltrap® 100 mg/4 mL SDV SOL SANAV 00024-5840-01 vl

J9400 Zaltrap® 200 mg/8 mL SDV SOL SANAV 00024-5841-01 vl

J8999 Zelboraf® 240 mg/112 tabs GNT 50242-0090-02 ea

J8999 Zydelig® 100 mg/60 tabs GIL 61958-1701-01 ea

J8999 Zydelig® 150 mg/60 tabs GIL 61958-1702-01 ea

Zykadia® 150 mg cap 70 NOV 00078-0640-70 ea

J8999 Zytiga® 250 mg/120 tabs JOM 57894-0150-12 btl

J8999 Zejula™ 100 mg cap 90 TSAR 69656-0103-90 btl

ASD Healthcare | 19

Your Patients. Your Purpose. Our Priority.

Convenient Connection ASD Healthcare makes it easy to order and reorder your inventory any time, any day, anywhere.

Connect at asdhealthcare.comCustomer Service 800.746.6273

One-Stop ShopMake ASD Healthcare your one-source distributor for

oncology and specialty pharmaceuticals.

Active Customers

95% of U.S. hospitals

88% of National Comprehensive Cancer

Network (NCCN) Centers

Oncology Market Share

35% of health systems

25% of specialty pharmacies

New Specialty Drugs

Contracted 98% of specialty drugs

launched within the past 12 months

ASD Oncology-Specialty Ad 100417.indd 1 10/4/17 12:58 PM

PharmaceuticalsPVaccinesCODE PRODUCT SIZE MFR. NDC # PK/CS

Flu - Trivalent Vaccines

CPT 90653 Fluad™ PFS 10 x 0.5 mL SEQ 70461-0019-03 pk

CPT 90662 Fluzone® High-Dose PFS 10 x 0.5 mL SAN 49281-0405-65 pk

Flu - Quadrivalent Vaccines

CPT 90688 Afluria® Quadrivalent MDV 5 mL SEQ 33332-0419-10 vl

CPT 90686 Afluria® Quadrivalent PFS 10 x 0.5 mL SEQ 33332-0319-01 pk

CPT 90685 Afluria® Quadrivalent Pediatric PFS 10 x 0.25 mL SEQ 33332-0219-20 pk

CPT 90686 Fluarix® Quadrivalent PFS 10 x 0.5 mL GSK 58160-0896-52 pk

CPT 90682 Flublok® Quadrivalent PFS 10 x 0.5 mL SAN 49281-0719-10 pk

CPT 90756 Flucelvax® Quadrivalent MDV 5 mL SEQ 70461-0419-10 vl

CPT 90674 Flucelvax® Quadrivalent PFS 10 x 0.5 mL SEQ 70461-0319-03 pk

CPT 90688 FluLaval® Quadrivalent MDV 5 mL GSK 19515-0897-11 vl

CPT 90686 FluLaval® Quadrivalent PFS 10 x 0.5 mL GSK 19515-0906-52 pk

CPT 90688 Fluzone® Quadrivalent MDV 5 mL SAN 49281-0631-15 vl

CPT 90686 Fluzone® Quadrivalent SDV 10 x 0.5 mL SAN 49281-0419-10 pk

CPT 90686 Fluzone® Quadrivalent PFS 10 x 0.5 mL SAN 49281-0419-50 pk

CPT 90685 Fluzone® Quadrivalent Pediatric 10 x 0.25 mL SAN 49281-0519-25 pk

Haemophilus B Conjugate

CPT 90647 Acthib® 5 SDV per pack SAN 49281-0545-03 pk

Hepatitis A

CPT 90633 Havrix Pediatric Tip-Lok 10/pk GSK 58160-0825-52 pk

CPT 90632 Havrix Adult 10 x 1 mL PF SDV GSK 58160-0826-11 pk

CPT 90633 Havrix Adult Tip-Lok 10/pk GSK 58160-0826-52 pk

Japanese Encephalitis

Ixiaro® 0.5 mL PFS VAL 42515-0002-01 syr

Meningococcal Meningitis

CPT 90734 Menactra 5 x 4 mcg/0.5 mL vl SAN 49281-0589-05 pk

MMR

CPT 90707 MMR II SDV 10/box MERCK 00006-4681-00 bx

Pneumococcal Conjugate for Bacterium Streptococcus Pneumoniae

CPT 90670 Prevnar 13® 10 x 0.5 mL PFS PFZ 00005-1971-02 pk

CPT 90670 Prevnar 13® 0.5 mL PFS PFZ 00005-1971-05 syr

TDAP

CPT 90715 Adacel® TDAP 10 x 0.5 mL vl SAN 49281-0400-10 pk

CPT 90715 Adacel® TDAP PFS 5/ctn SAN 49281-0400-15 pk

CPT 90715 Adacel® TDAP 5 x 0.5 mL PFS SAN 49281-0400-20 pk

CPT 90715 Boostrix TDAP 10 x 0.5 mL SDV GSK 58160-0842-11 pk

Tetanus and Diptheria

CPT 90714 Tenivac® TD PFS 10/ctn 0.5 mL SAN 49281-0215-15 pk

ASD Healthcare | 21

PharmaceuticalsP


Tuberculosis

CPT 86580 Aplisol® 5 TU 1 mL PAR 42023-0104-01 pk

CPT 86580 Aplisol® 5 TU 5 mL PAR 42023-0104-05 pk

CPT 86580 Tubersol® 5 TU 1 mL SAN 49281-0752-21 pk

CPT 86580 Tubersol® 5 TU 5 mL SAN 49281-0752-22 pk

Hepatitis A and Hepatitis B

Twinrix® Tiploks 10/pk GSK 58160-0815-52 pk

SpecialtyCODE PRODUCT SIZE MFR. NDC # PK/CS

J3262 Actemra® Intravenous 80 mg/4 mL SDV GNT 50242-0135-01 vl



J3490 Actemra® Subcutaneous 162 mg PFS 0.9 mL GNT 50242-0138-01 syr

J2997 Activase® 50 mg GNT 50242-0044-13 vl

J2997 Activase® 100 mg GNT 50242-0085-27 vl

J2997 Activase® Cathflo 2 mg GNT 50242-0041-64 vl

J3490 Ammonul® 50 mL VAL 00187-0010-50 vl

J8499 Ampyra® 10 mg/60 tabs ACO 10144-0427-60 btl

Arikayce® 590 mg/8.4 mL INS 71558-0590-28 vl

J0490 Benlysta® 120 mg SDV GSK 49401-0101-01 vl

J0490 Benlysta® 400 mg SDV GSK 49401-0102-01 vl

J0490 Benlysta® 200 mg auto-injector GSK 49401-0088-35 pk

J0490 Benlysta® 200 mg PFS GSK 49401-0088-47 pk

J0597 Berinert® 500 iu CSL 63833-0825-02 vl

J7685 Bethkis® 300 mg/4 mL CHIE 10122-0820-56 bx

J8499 Buphenyl® 500 mg tabs HRZN 75987-0060-08 btl

J3490 Buphenyl® 250 g powder HRZN 75987-0070-09 btl

J0600 Calcium Disodium Versenate 1000 mg/5 mL VAL 99207-0240-05 pk

J2786 Cinqair® 100 mg/10 mL SDV TEVA 59310-0610-31 vl

J0840 CroFab® 2 x 2 mL BTG 50633-0110-12 pk

J0878 Cubicin® 500 mg MERCK 67919-0011-01 10/pk

J0878 Cubicin® RF 500 mg MERCK 67919-0012-01 10/pk

J0878 Daptomycin 500 mg/10 mL TEVA 00703-0125-01 vl

Daraprim® 25 mg/30 tabs TUR 69413-0330-30 btl

Daraprim® 25 mg/100 tabs TUR 69413-0330-10 btl

J0894 Decitabine 50 mg PWD SDV DRE 55111-0556-10 vl

J1162 DigiFab® 40 mg BTG 50633-0120-11 vl

Endari™ 5 g powder 60/box EMM 42457-0420-60 box

J3590 Entyvio® 300 mg/20 mL SDV TAK 64764-0300-20 ea

NEW

22 | I ns ideOut



J7503 Envarsus® XR 0.75 mg/30 tabs VLX 68992-3075-03 btl

J7503 Envarsus® XR 0.75 mg/100 tabs VLX 68992-3075-01 btl

J7503 Envarsus® XR 1 mg/30 tabs VLX 68992-3010-03 btl




Esbriet® 267 mg/270 caps GNT 50242-0121-01 ea

Esbriet® 267 mg/270 tabs GNT 50242-0122-06 ea

Esbriet® 801 mg/90 tabs GNT 50242-0123-01 ea

J8499 Exjade® 125 mg/30 tabs NOV 00078-0468-15 btl



J1428 Exondys 51™ 100 mg/2 mL SDV SRPT 60923-0363-02 vl

J1428 Exondys 51™ 500 mg/10 mL SDV SRPT 60923-0284-10 vl

J0517 Fasenra™ 30 mg PFS ASTRA 00310-1730-30 syr

J3490 Gattex® 5 mg SDV NPS 68875-0103-01 vl

J3490 Gattex® 30 mg vl kit NPS 68875-0102-01 vl

Giapreza™ 2.5 mg/mL 1 mL vial LAJO 68547-0501-02 vl

Glatopa® 12 x 40 mg/mL PFS SAND 00781-3250-89 pk

Q9995 Hemlibra® 30 mg/mL SDV GNT 50242-0920-01 vl

Q9995 Hemlibra® 60 mg/0.4 mL SDV GNT 50242-0921-01 vl

Q9995 Hemlibra® 105 mg/0.7 mL SDV GNT 50242-0922-01 vl

Q9995 Hemlibra® 150 mg/mL SDV GNT 50242-0923-01 vl

Ilumya™ 100 mg/mL SOL SUN 47335-0177-95 vial

Ingrezza® 40 mg cap 30/btl NEBSC 70370-1040-01 btl

Ingrezza® 80 mg cap 30/btl NEBSC 70370-1080-01 btl

J1290 Kalbitor® 10 mg DYAX 47783-0101-01 vl

J2840 Kanuma® 20 mg/10 mL ALX 25682-0007-01 vl



J8499 Korlym® 300 mg/28 tabs COR 76346-0073-01 btl

J9047 Kyprolis® 10 mg powder Lyo SDV AMG 76075-0103-01 vl

J9047 Kyprolis® 30 mg powder Lyo SDV AMG 76075-0102-01 vl

J9047 Kyprolis® 60 mg powder SDV AMG 76075-0101-01 vl

Macrilen™ 60 mg pouch STN 71090-0002-02 ea

Miglustat 100 mg cap 90 (15 x 6) AMER 43975-0310-83 pk

J0587 Myobloc® 2500 units/0.5 mL SOL 10454-0710-10 vl

J0587 Myobloc® 5000 units/1 mL SOL 10454-0711-10 vl

J0587 Myobloc® 10000 units/2 mL SOL 10454-0712-10 vl

CPT 96372 Natpara® 75 mcg dual cartridge NPS 68875-0204-02 ea

CPT 96372 Natpara® 100 mcg dual cartridge NPS 68875-0205-02 ea

J3490 Neoprofen® 10 mg/mL SDV 3 x 2 mL REC 55292-0122-52 vl

NEW

ASD Healthcare | 23

PharmaceuticalsPCODE PRODUCT SIZE MFR. NDC # PK/CS

J2182 Nucala® 100 mg GSK 00173-0881-01 vl

Nuplazid™ 10 mg/30 tabs ACAD 63090-0100-30 btl

Nuplazid™ 34 mg/30 caps ACAD 63090-0340-30 btl

J2941 Nutropin AQ® 5 mg/2 mL Nuspin inj GNT 50242-0075-01 ea



J2350 Ocrevus® 300 mg/10 mL SDV GNT 50242-0150-01 vl

Ofev® 100 mg/60 gel caps BIP 00597-0143-60 ea

Ofev® 150 mg/60 gel caps BIP 00597-0145-60 ea

C9447 Omidria™ 1%/0.3% SDV 4 x 4 mL OME 62225-0600-04 vl

J1640 Panhematin® 350 mg REC 55292-0702-55 vial

Panretin® 0.1% Gel 60 gm EISAI 62856-0601-22 ea

J3490 Praxbind® 2.5 g/50 mL 1 x 2 mL BIP 00597-0197-05 ea

J8499 Promacta® 12.5 mg/30 tabs NOV 00078-0684-15 ea

J8499 Promacta® 25 mg/30 tabs NOV 00078-0685-15 ea



J7336 Qutenza® single patch kit AVER 10144-0928-01 kit

J7336 Qutenza® double patch kit AVER 10144-0929-01 kit

J3490 Radicava® 30 mg/100 mL x 2 bags/pk MTPA 70510-2171-02 pk

J2547 Rapivab® 200 mg/200 mL 1 x 3 vls SEQ 61364-0181-03 vl

J8499 Ravicti® 25 mL HRZN 75987-0050-06 vl

SalivaMAX™ 351 mg 120/bx FORW 70275-0629-12 bx

Sinuva™ sinus implant INTER 10599-0003-01 ea

Sodium Phenylacetate and Sodium Benzoate Injection

50 mL SDV generic* 13811-0705-50, 68382-0396-01

vl

J1930 Somatuline® Depot 60 mg PFS IPSN 15054-1060-03 syr



C9482 Sotalol IV 150 mg/10 mL ALTA 69724-0112-10 vl

J3357 Stelara® 45 mg PFS 0.5 mL JAN 57894-0060-03 syr

J3357 Stelara® 90 mg PFS 1 mL JAN 57894-0061-03 syr

J3357 Stelara® 45 mg SDV 0.5 mL JAN 57894-0060-02 vl

J3358 Stelara® IV 130 mg SDV JAN 57894-0054-27 vl

J3490 Strensiq® 18 mg/0.45 mL vls 12/pk ALX 25682-0010-12 pk


J3490 Strensiq® 40 mg/mL vls 12/pk ALX 25682-0016-12 pk


J2680 Sylvant® 100 mg Lyo powder SDV JOM 57894-0420-01 vl

J2860 Sylvant® 400 mg Lyo powder SDV JOM 57894-0421-01 vl

Tavalisse 100 mg/60 tabs RIGEL 71332-0001-01 ea

Tavalisse 150 mg/60 tabs RIGEL 71332-0002-01 ea

Tegsedi™ 4 x 284 mg/1.5 mL PFS AKC 72126-0007-01 pk


NEW

24 | I ns ideOut



Triptodur® 22.5 mg kit ARBR 24338-0150-20 kit

J2323 Tysabri® 300 mg/15 mL BIOG 64406-0008-01 vl

J3490 Varithena® 18 mL/inj BIOCO 60635-0118-01 ea

J3490 Varithena® admin pack BIOCO 60635-0123-01 ea

J8670 Varubi™ 90 mg tab 2/pk TES 69656-0101-02 pk

C9293 Voraxaze® 1000 units/vl BTG 50633-0210-11 1 vl/cn

J2357 Xolair® 150 mg GNT 50242-0040-62 vl

Zemdri™ 500 mg 10 mL SDV ACH 71045-0010-02 vial

J0695 Zerbaxa® 10 x 1 g/0.5 g SDV MERCK 67919-0030-01 pk

Q9993 Zilretta® 32 mg FLEX 70801-0003-01 vl

Biosurgery ProductsCODE PRODUCT SIZE MFR. NDC # PK/CS

C9250 Artiss Fibrin Sealant PFS 2 mL BAX 00338-8503-02 ea



600038 Cannula DuploTip 20 g x 32 cm BAX 10/cs

934070 CoSeal™ 2 mL BAX vl



921022 Duplocath 25 BAX ea

600012 EasySpray Pressure Regulator BAX ea

600013 EasySpray Set BAX 10/cs

934057 FloSeal Matrix Hemostatic Sealant 6 x 5 mL BAX cs

934050FloSeal NT Matrix Hemostatic Sealant

6 x 5 mL BAX cs

934055FloSeal Reusable Endoscopic Applicator

BAX ea

1500181 FloSeal Endoscopic Applicator BAX 6/cs

934208 FloSeal Curved Applicator Tip 8 cm BAX ea

934210 FloSeal Curved Applicator Tip 10 cm BAX ea

J3490 Tisseel Frozen 2 mL BAX 00338-8402-02 ea



921028 Tisseel VH 2 mL S/D kit BAX 00338-4301-02 ea



921051VP ValuPak 2 mL (1 cs TISSEEL Biologic-Only and 1 cs DUPLOJECT EASY PREP)

6 x 2 mL BAX 00338-4210-02 cs


6 x 4 mL BAX 00338-4302-04 cs


6 x 10 mL BAX 00338-4212-10 cs

ASD Healthcare | 25

Contrast MediaCM

BraccoASD # MFR # DESCRIPTION SIZE NDC # PK/CS

Oral Contrast Agents - CT Barium

49284 7450 Readi-Cat Banana 450 mL 32909-0722-03 24/cs

48869 7150 Readi-Cat Berry 450 mL 32909-0711-03 24/cs

48887 7550 Readi-Cat Creamy Vanilla 450 mL 32909-0756-03 24/cs

48888 4503-07 Readi-Cat Mochaccino 450 mL 32909-0777-03 24/cs

48886 723 Readi-Cat2 Barium 2.1% 450 mL 32909-0724-03 24/cs

35369 4507-01 Volumen 0.1% 450 mL 32909-0945-03 24/cs

Double Contrast Colon Examination

36703 L168 Liquid Polibar PLS 105% 1900 mL 32909-0168-02 4/cs

Routine Upper GI Examination

36063 9021-01 E-Z Paste 16 oz 32909-0770-01 12/cs

36061 9019-01 E-Z Paque 6.2 oz 32909-0750-03 24/cs

36062 9028-01 E-Z Paque 12 oz 32909-0186-02 24/cs

Double Contrast Examination of Esophagus, Stomach and Duodenum

35699 9017-02 E-Z HD 98% w/w susp 12 oz 32909-0764-01 24/cs

Fluoroscopy

35997 9020-01 E-Z Gas II Granules 10361-0793-01 50/cs

38938 9021-02 E-Z Disc 10 Grain Tabs 10361-0778-31 100/cs

Modified Barium Swallowing Studies

36719 9000-01 Varibar Barium Thin liquid 148 g 32909-0105-10 24/cs

36720 9000-02 Varibar Barium Nectar 240 mL 32909-0115-00 24/cs

36721 9000-04 Varibar Barium Thin Honey 250 mL 32909-0121-07 12/cs

36722 9000-05 Varibar Barium Honey 250 mL 32909-0122-07 12/cs

36723 9000-06 Varibar Barium Pudding 230 mL 32909-0125-22 12/cs

Small Bowel/Enteroclysis Studies

36734 9014-07 Entero Vu 24% 600 mL 32909-0145-06 12/cs

Ultrasound Gels and Disinfecting Towelettes

36307 6010-01 E-Z Gel Refill Bottle 8 oz 00270-6010-01 12/cs

Stool Tagging Agent

Tagitol Fecal Tag Agent 32909-0814-53 24/cs

Fluid Collection Device

Vinyl Retention Enema Ring 00270-9011-01 12/cs

26 | I ns ideOut

ASD # DESCRIPTION NDC # MANUFACTURER

Antibiotics

24330 Amikacin Sulfate 250 mg 4 mL 00703-9040-03 Teva Pharmaceuticals USA

37063 Amikacin Sulfate 250 mL vl 10 x 2 mL 00703-9032-03 Teva Pharmaceuticals USA

Avycaz® 2/0.5 g SDV 00456-2700-10 Allergan

40377 Cefazolin 1 gm SDV 25/10 mL 00143-9924-90 Westward

48447 Cefazolin 500 mg vl 25/pk 00143-9923-90 Westward

30605 Cefazolin Sod 1 mg IV adv 25/pk 00409-2585-01 Pfizer Injectables

34185 Cefazolin 1 gm SDV 25/10 mL 00409-0805-01 Pfizer Injectables

39218 Cefazolin 1 gm vl 25/pk 25021-0101-10 Sagent Pharmaceuticals

48447 Cefazolin 500 mg vl 25/pk 25021-0100-10 Sagent Pharmaceuticals

20074 Cefazolin 500 mg vl 25/10 mL 63323-0236-10 Fresenius Kabi USA LLC

37505 Ceftazidime 1 gm SDV 20 mL 25/pk 25021-0127-20 Sagent Pharmaceuticals

37506 Ceftazidime 2 gm 50 mL 25021-0128-50 Sagent Pharmaceuticals

26591 Ceftriaxone 1 gm 00409-7332-01 Pfizer Injectables

40401 Ceftriaxone 2 gm 00143-9856-25 Westward/Baxter

45652 Ciprofloxacin 400 mg SDV 40 mL ea 36000-0011-01 Claris Lifesciences Inc.

35066 Ciprofloxacin 750 mg Tab 50 16252-0516-05 Actavis/Watson Pharmaceuticals

51574 Daptomycin 350 mg SDV 25021-0179-15 Sagent Pharmaceuticals

47387 Daptomycin 500 mg vial 10 mL 00703-0125-01 Teva Pharmaceuticals USA

40751 Fortaz® 500 mg vl 10/pk 24987-0377-10 Teligent Pharma, Inc.

26708 Gentamicin 40 mg/mL FTV 25 x 2 mL 00409-1207-03 Pfizer Injectables

13322 Gentamicin Top crm 15 gm 45802-0046-35 Perrigo Pharmaceuticals Co.

13321 Gentamicin Top 0.1% crm 15 gm 45802-0056-35 Perrigo Pharmaceuticals Co.

46098 Levofloxacin 500 mg 20 mL SDV 17478-0107-20 Akorn Inc.

27620 Tazicef™ 1 gm SDV 25 x 20 mL 00409-5082-16 Pfizer Injectables

32181 Tazicef™ 2 gm vl 10 x 60 mL 00409-5084-11 Pfizer Injectables

46438 Tazicef™ 1 gm ADV SDV 25 X 1 gm 00409-5092-16 Pfizer Injectables

46969 Tazicef™ 2 gm ADV SDV 10 X 2 gm 00409-5093-11 Pfizer Injectables

26111 Vancomycin 1 gm SDV FTV 10/bx 00409-6533-01 Pfizer Injectables

26216 Vancomycin 500 mg FTV 10/bx 00409-4332-01 Pfizer Injectables

Calcimimetics

50043 Parsabiv™ 2.5 mg/0.5 mL SDV 10 x 0.5 mL 55513-0740-10 Amgen Inc.

50044 Parsabiv™ 5 mg/mL SDV 10 x 1 mL 55513-0741-10 Amgen Inc.

50045 Parsabiv™ 10 mg/2 mL SDV 10 x 2 mL 55513-0742-10 Amgen Inc.

24632 Sensipar® 30 mg tab 30 55513-0073-30 Amgen Inc.



ESAs

28198 Aranesp® 25 mcg SDV 4 x 1 mL 55513-0002-04 Amgen Inc.




28203 Aranesp® 200 mcg SDV 1 mL 55513-0006-01 Amgen Inc.

44483 Aranesp® 10 mcg PFS 4 x 0.4 mL 55513-0098-04 Amgen Inc.


NephrologyN

ASD Healthcare | 27

NephrologyNASD # DESCRIPTION NDC # MANUFACTURER





28196 Aranesp® 200 mcg PFS 0.4 mL 55513-0028-01 Amgen Inc.

28197 Aranesp® 300 mcg PFS 0.6 mL 55513-0111-01 Amgen Inc.

28140 Aranesp® 500 mcg PFS 1 mL 55513-0032-01 Amgen Inc.

11294 Epogen® S2 2 M un/mL vl 10 x 1 mL 55513-0126-10 Amgen Inc.




11177 Epogen® M10 20 M un/2 mL MDV 10 x 2 mL 55513-0283-10 Amgen Inc.

11508 Epogen® M20 20 M un/mL MDV 10 x 1 mL 55513-0478-10 Amgen Inc.

10510 Procrit® 10 M un/mL vl 6 x 1 mL 59676-0310-01 JOM Pharmaceutical

11190 Procrit® 10 M un/mL 1 mL 25/pk 59676-0310-02 JOM Pharmaceutical

31310 Procrit® 10 M un/mL 2 mL MDV 4/pk 59676-0312-04 JOM Pharmaceutical

30696 Procrit® 20 M un/mL MDV 4 x 1 mL 59676-0320-04 JOM Pharmaceutical

10982 Procrit® 40 M un/mL vl 4 x 1 mL 59676-0340-01 JOM Pharmaceutical

Vaccines, Hep. B

30326 Engerix-B® Adult 20 mcg SDV 10 X 1 mL 58160-0821-11 Glaxosmithkline Vaccines

30218 Engerix-B® Adult 20 mcg TIPLK 10/pk 58160-0821-52 Glaxosmithkline Vaccines

43204 Pneumovax® 23 PFS 10/pk 00006-4837-03 Merck & Co.

38983 Prevnar-13 PFS 10 x 0.5 mL 00005-1971-02 Pfizer

41022 Prevnar-13 PFS 0.5 mL 00005-1971-05 Pfizer

22353 Recombivax® DF 40 mcg/mL PF 1 mL 00006-4992-00 Merck & Co.

22719 Recombivax® 10 mcg 1 mL (pediatric) 00006-4995-00 Merck & Co.

Heparin

41859 Heparin 1000 u/mL MDV 10 x 30 mL 00069-0137-03 Pfizer Injectables

11778 Heparin 1000 u/mL MDV 25 x 30 mL 63323-0540-31 Fresenius Kabi USA LLC

36901 Heparin 1000 u/mL MDV 25 x 30 mL 25021-0400-30 Sagent Pharmaceuticals

33874 Heparin 5000 u/mL MDV 25 x 10 mL 00409-2723-02 Pfizer Injectables

36906 Heparin sod 5 M MDV vl 25 x 10 mL 25021-0402-10 Sagent Pharmaceuticals

37216 Heparin sod 10 M un MDV 25 x 1 mL 25021-0403-01 Sagent Pharmaceuticals

37217 Heparin sod 1 M un/mL MDV 25 x 10 mL 25021-0400-10 Sagent Pharmaceuticals

51078 Heparin sod 1 M un MDV 25 x 10 mL 00069-0058-01 Pfizer Injectables

33873 Heparin sod 1 M un/mL MDV 25 x 30 mL 00409-2720-03 Pfizer Injectables

37215 Heparin sod 5 mL un MDV 25 x 1 mL 25021-0402-01 Sagent Pharmaceuticals

51502 Heparin sod 5 M un vl 25 x 10 mL 00069-0059-01 Pfizer Injectables

37218 Heparin sod 10 M un MDV 25 x 4 mL 25021-0403-04 Sagent Pharmaceuticals

11480 Heparin sod 10 M un MDV 25 x 1 mL 63323-0542-01 Fresenius Kabi USA LLC

40767 Heparin sod PF 1000 un/mL 25 x 2 mL 25021-0401-02 Sagent Pharmaceuticals

40765 Heparin sod 1000 un/mL 25 x 1 mL 25021-0400-01 Sagent Pharmaceuticals

17773 Heparin 5000 u/mL MDV 25 x 10 mL 63323-0047-10 Fresenius Kabi USA LLC

28 | I ns ideOut



Iron

37769 Ferrlecit® 62.5 mg/5 mL vl 10 x 5 mL 00024-2792-10 Sanofi-Aventis US LLC

34408 Feraheme® 510 mg/17 mL SDV 59338-0775-01 Amag

34409 Feraheme® 510 mg/17 mL SDV 10/pk 59338-0775-10 Amag

22668 Infed® 50 mg/mL vl 10 x 2 mL 52544-0931-02 Allergan

41523 Injectafer® SDV 750 mg/15 mL 00517-0650-01 American Regent

45094Sodium Ferric Gluconate Sucrose Injection 62.5 mg x 5 mL 10/pk

00143-9570-10 Westward

Triferic® 24 x 50 mL 57278-0314-02 Rockwell Medical

37214 Venofer® 50 mg SDV 10 x 2.5 mL 49230-0530-10 Fresenius Medical Services

33100 Venofer® 100 mg SDV 10 x 5 mL 49230-0534-10 Fresenius Medical Services

33101 Venofer® 100 mg SDV 25 x 5 mL 49230-0530-25 Fresenius Medical Services

39908 Venofer® 50 mg SDV 25 x 2.5 mL 49230-0530-25 Fresenius Medical Services

Vitamin D

37547 Calcitriol 0.25 mcg caps 100/btl 64380-0723-06 Strides Acrolab

37548 Calcitriol 0.5 mcg caps 100/btl 64380-0724-06 Strides Acrolab

37813 Calcitriol Oral Solution 1 mcg 15 mL 00054-3120-41 Roxanne

38711 Calcitriol 1 mcg/mL amp 10 x 1 mL 17478-0931-01 Akorn Inc.

48858 Doxercalciferol 4 mcg MDV 50 x 2 mL 70121-1408-05 Amneal Biosciences

37299 Hectorol® 2 mcg SDV 50 x 1 mL 58468-0126-01 Sanofi Genzyme

33705 Hectorol® 4 mcg SDV 50 x 2 mL 58468-0123-01 Sanofi Genzyme

43059 Hectorol® 4 mcg MDV 50 x 2 mL 58468-0127-01 Sanofi Genzyme

46223 Paracalcitol 2 mcg MDV 25 x 1 mL 16729-0310-08 Accord Healthcare Inc.



37232 Zemplar 1 mcg caps 30/btl 00074-4317-30 AbbVie Inc.


20967 Zemplar 2 mcg/mL vl 25 x 1 mL 00074-4637-01 AbbVie Inc.


10001 Zemplar 5 mcg/mL 25 x 1 mL FTV 00074-1658-01 AbbVie Inc.

37381 Zemplar 10 mcg/2 mL MDV 25 x 2 mL 00074-1658-05 AbbVie Inc.

Other / Ancillary Rx

37180 Acetaminophen 325 mg tab 100 00904-1982-60 Major Pharmaceuticals

28520 Acetaminophen 325 mg tab UD 100 00904-1982-61 Major Pharmaceuticals

52404 Acetaminophen 500 mg tab UD 100 00904-6730-61 Major Pharmaceuticals

20363 Activase® Cathflo® 2 mg SDV 50242-0041-64 Genentech USA

22092 Allopurinol 300 mg/100 tabs 53489-0157-01 Major Pharmaceuticals

45206 Antacid XS Fruit Chew 96/pk 00536-1049-22 Major Pharmaceuticals

31842 Aplisol® 5 TU 10 test vl 1 mL 42023-0104-01 Par Sterile Products LLC

31843 Aplisol® 5 TU 50 test vl 5 mL 42023-0104-05 Par Sterile Products LLC

35293 Atropine AN syr 0.1 mg/mL 10 X 10 mL 00409-1630-10 Pfizer Injectables

32464 Atropine LFS syr 10 mL 0.1 mg/mL 00409-4911-34 Pfizer Injectables

40085 Atropine LJT syr 1 mg 10 x 10 mL 76329-3339-01 Intl Medication System Limited

21531 Atropine 1 mg/mL SDV PF 1 mL ea 00517-1010-25 American Regent

22203 Atropine Sul 1 mg/mL PF SDV 25 x 1 mL 00517-1010-25 American Regent

NEW

ASD Healthcare | 29

NephrologyNASD # DESCRIPTION NDC # MANUFACTURER

45343 Bupropion 300 mg/30 tabs 68001-0264-04 American Health Packaging

46119 Calcium Chloride 10% ls abj syringe 20 g x 10 00409-4928-34 Pfizer Injectables

27609 Calcium Chloride Ansyringe 10% 10 x 10mL 00409-1631-10 Pfizer Injectables

20490 Carnitor® 1 gm/5 mL SDV 5 x 5 mL 54482-0147-01 Leadiant Biosciences, Inc.

36583 Cefepime 1gm SDV 20 mL 10/pk 25021-0121-20 Sagent Pharmaceuticals

36584 Cefepime 2gm SDV 50 mL 10/pk 25021-0122-50 Sagent Pharmaceuticals

36226 Cefidinir 300 mg cap 60/btl 68180-0711-60 Lupin Pharma

49178 Cefotan 2 gm vl 10 x 20 mL 52565-0053-10 Teligent Pharma, Inc.

10093 Clonidine 0.1 mg tab 100/btl 00228-2127-10 Actavis



50249 Cryodose Ta Mist Spray 115 mL Nuance Medical LLC

51455 Cryodose Ta Mist Stream 115 mL Nuance Medical LLC

27537 Dextrose 50% ANSYR 25 gm/50 mL 00409-7517-16 Pfizer Injectables

27423 Dextrose 50% LFS SYG 50 mL 00409-4902-34 Pfizer Injectables

26223 Dextrose 50% vl 50 mL 00409-6648-02 Pfizer Injectables

38759 Diphenhydramine 25 mg UD 100/pk 00904-5306-61 Major Pharm

11153 Diphenhydramine 50 mg vl 25 x 1 mL 00641-0376-25 Westward

22253 Diphenhydramine 50 mg vl 25 x 1 mL 63323-0664-01 Fresenius Kabi USA LLC

46123 Epinep 1:1000 amp 25 x 1 mL 00409-7241-01 Pfizer Injectables

49324 Epinephrine 1 mg/mL pf sf 1 mL Amp Each 54288-0103-01 BPI Labs Inc.

48229 Epinephrine 1 mL/mL pf sf 1 mL Amp 10/pk 54288-0103-10 BPI Labs Inc.

27478 Epinep 1:10000 20 g abjct 10 mL X 10 00409-4921-34 Pfizer Injectables

34632 EpiPen adult 0.3 mg 2/pk 49502-0500-02 Mylan Specialty L.P.

34631 EpiPen Jr 0.15 mg 2/pk 49502-0501-02 Mylan Specialty L.P.

47931 Epinephrine 0.3 mg autoinj 2/pk (generic) 49502-0102-02 Mylan Specialty L.P.

27906 Gelfoam® 12-7 mm spg 12/pk 00009-0315-08 Pfizer Injectables

Glucose Fast Acting Tab 10 00904-6710-15 Major Pharmaceuticals

40021 Hydrogen Peroxide 3% Liq 16 oz ea 00869-0871-43 ABDC

10063 Insulin Hum R 100 u/mL vl 10 mL 00002-8215-01 Eli Lilly & Co

36002 Insulin Hum 100 u/mL vl 3 mL 00002-8215-17 Eli Lilly & Co

32794 Lidocaine 0.5% FTV 25 X 5 mL 00409-4275-01 generic*

27029 Lidocaine 1% ansyr syg 5 mL ea 00409-9137-05 generic*

46111 Lidocaine 1% FTV MDV 25 x 20 mL 00409-4276-01 Pfizer Injectables

26653 Lidocaine 1% FTV MDV 25 x 50 mL 00409-4276-02 Pfizer Injectables

26659 Lidocaine 2% FTV 25 x 50 mL 00409-4277-02 generic*

27452 Lido Ansyr 2% Syringe 10 x 5 mL 00409-1323-05 Pfizer Injectables

27319 Lido 2% Syringe 10 x 5 mL 00409-4903-34 Pfizer Injectables

37309 Lido/Prilo Cream 2.5% 30 gm 50383-0667-30 Akorn Inc.

50747 Lisinopril 2.5 mg/100 tabs 68001-0332-00 American Health Packaging

20078 Loperamide 2 mg cap 100/btl 00093-0311-01 Teva Pharmaceuticals USA

36031 Mannitol 25% FTV 25 x 50 mL 00409-4031-01 Pfizer Injectables

11474 Mannitol 25% SDV 25 x 50 mL 63323-0024-25 Fresenius Kabi, LLC


NEW

30 | I ns ideOut



40755 MaxipimeTM 1 gm FTV PWD 10/pk 00409-0219-01 Pfizer Injectables

40756 MaxipimeTM 2 gm FTV PWD 10/pk 00409-0220-01 Pfizer Injectables

48903 Metoclopram 10 mg/2 mL FTV 25 X 2 mL 00409-3414-18 Pfizer Injectables

17899 Metoclopramide 10 mg tab 100 00093-2203-01 Teva Pharmaceuticals USA

45829 Midodrine HCL 5 mg UD/100 tab 51079-0453-20 Mylan Specialty L.P.

28004 Mupirocin 2% ointment 22 gm 45802-0112-22 Perrigo Pharmaceuticals Co

Olmesartan 20 mg/30 tabs 00378-7112-93 Mylan Specialty L.P.

J2405 Ondansetron 2 mg/mL SDV 2 mL 00409-4755-03 Pfizer Injectables

26843 Pain ease 3.5 oz spray 00386-0008-03 Gebauer Company

32320 Pain ease 3.5 oz spray mist 00386-0008-02 Gebauer Company

39202 Phenergan 25 mg 1 mL 25/pk 00641-6082-25 Westward/Baxter

32546 Phenytoin Sod 250 mg 5 mL vl 00641-2555-41 Westward/Baxter

11151 Promethazine 25 mg/mL amp 25 x 1 mL 00641-1495-35 Westward/Baxter

28419 Promethazine 25 mg/mL SDV 25 x 1 mL 00641-0928-25 Westward/Baxter

10744 Promethazine HCL 25 mg 100/btl 00781-1830-01 Sandoz

24546 Promethazine 25 mg tab 100/btl 00591-5307-01 Actavis/Watson Pharmaceuticals

30170 Promethazine 25 mg tab 100/btl 68382-0041-01 Zydus Pharmaceuticals

27114 Sod Chl 0.9% ADV bag 24 x 250 mL 00409-7101-02 Pfizer Injectables

26191 Sod Chl 0.9% FTV PFV 25 x 10 mL 00409-4888-10 Pfizer Injectables

27706 Sod Chl 12 mL syr 10 mL 180/cs 08881-5701-21 Covidien Sales, LLC

46106 Sod Chl Bact 0.9% MDV 25 x 30 mL 00409-1966-07 Pfizer Injectables

28804 Sod Chl 23.4% INJ 25 x 10 mL 00409-1141-02 Pfizer Injectables

27615 Sod Bic 8.4% Ls syg 50 mL ea 00409-6637-34 Pfizer Injectables

26054 Sod Bic 8.4% FTV 25 x 50 mL 00409-6625-02 Pfizer Injectables

41958 Sod Thiosulfate Inj 12.5/50 mL 60267-0705-50 Hope Pharmaceuticals

37007 Triple Anti Oint Foil 144 x 0.9 gm Dynarex Corp

20609 Tubersol® 5 TU 10 test vl 1 mL 49281-0752-21 Sanofi Pasteur

19969 Tubersol® 5 TU 50 test vl 5 mL 49281-0752-22 Sanofi Pasteur

26656 Water Sterile FTV 25 x 10 mL 00409-4887-10 Pfizer Injectables


26193 Water Bact vl 25 x 30 mL 00409-3977-03 Pfizer Injectables



ASD Healthcare | 31

Medical / SurgicalMSASD # DESCRIPTION MANUFACTURER PK/CS

Top Disposable Products

35009 Alcohol Prep Pad Med. (sterile) Dynarex 200/bx

27969 Alcohol Swabsticks 3'S Dynarex 25/bx

32474 Apron Gowns Disposable 28" x 46" (plastic) Busse 144/cs

32710 Catheter Cap (injectable) Latex Free Molded 100/bx

18784 Catheter Cap (dead end/non-injectable) B. Braun 100/bx

26860 Chloraprep® Single Swabstick Tacy Med 48/bx

37287 Cotton Tip Applicators 6" Sterile 2’s Hardwood 100/bx

32475 Drape Sheet 18" x 26" (other sizes available) Busse 50/bx

26857 Drape Sheet 40" x 48" 2 ply TIDI 100/cs

36048 Drape Sheet 40" x 90" 3 ply TIDI 50/cs

34089 Emesis Basin 9" Medline 250/cs

32618 Fistula Pressure Clamps (plastic) Molded 1/ea

35908 Hemastix Test Strips Siemens 50/bx

32709 Hemoband® (non-sterile) Hemoband 1/ea

32761 Luer Lock End Caps – blue Molded 100/bx

18534 Mask – blue (ear loop) Dynarex 50/bx

14837 Mask – blue (molded) Dynarex 50/bx

18318 Medicine Cups 1 oz Dynarex 100/bx

32538 Oxygen Mask Rebreather – adult Allied 1/ea

15184 Oxygen Nasal Cannula – adult Allied 1/ea

14844 Povidone/Iodine Prep Pads (PVP pads) Dynarex 100/bx

14840 Povidone/Iodine Swabsticks (1 per pack) Dynarex 50/bx

28053 Povidone/Iodine Swabsticks (3 per pack) Dynarex 75/bx

32754 Recirculating Connector (male to male) Molded 100/bx

32414 Shoe Covers – blue (one size fits all) Dynarex 150/pairs

26355 Skin Staple Remover Kits Busse 1/ea

20941 Suture Removal Kits Busse 1/ea

15598 Table Paper 21" x 225' Smooth TIDI 12/cs

20568 Towel 3 ply 13.5" x 18" White 500/cs Graham 500/cs

14815 Tape Remover Pads (sterile) Dynarex 100/bx

32643 Transducer Protector (w/luer lock) Molded 100/cs

32755 Tube Occluding Clamp – blue (hemostats) Molded 100/bag

25875 Underpad 17" x 24" (blue) Chux Dynarex 300/cs

33864 Urinals w/Cover (plastic disposable) Medline 1/ea

15601 Wash Cloths 10" x 13.5" – blue (disposable) Graham 500/cs

32 | I ns ideOut


ASD # DESCRIPTION MANUFACTURER PK/CS

Gloves

39657 Gloves PF Latex Small Tradex 100/bx

39658 Gloves PF Latex Medium Tradex 100/bx

39659 Gloves PF Latex Large Tradex 100/bx

39660 Gloves PF Latex X-Large Tradex 100/bx

39653 Gloves PF Vinyl Small Tradex 100/bx

39654 Gloves PF Vinyl Medium Tradex 100/bx

39655 Gloves PF Vinyl Large Tradex 100/bx

39656 Gloves PF Vinyl X-Large Tradex 100/bx

41762 Gloves PF Nitrile Small Tradex 200/bx

41763 Gloves PF Nitrile Medium Tradex 200/bx

41764 Gloves PF Nitrile Large Tradex 200/bx

41765 Gloves PF Nitrile X-Large Tradex 200/bx

32407 Gloves Sterile Latex Medium (Small and Large Available) Dynarex 50/pairs

Lab Coats

39797 Lab Coat White No Pkt Small Dynarex 30/cs

39795 Lab Coat White No Pkt Medium Dynarex 30/cs

39794 Lab Coat White No Pkt Large Dynarex 30/cs

39796 Lab Coat White No Pkt X-Large Dynarex 30/cs

39836 Lab Coat White No Pkt XX-Large Dynarex 30/cs

Sharps Containers

22352 Sharps Container 2 gallon – red (# 8970) Square Covidien 20/cs


32727 Sharps Container 3 gallon – red (# 8964) Covidien 20/cs


32042 Sharps Container 8 gallon – red (# 8980S) Slide Lid Covidien 10/cs

11973 Sharps Container 18 gallon – red Covidien 1/ea

32623 Sharps Container – brackets 2 and 3 gallon Covidien 1/ea

Thermometers

32742 Genius® Probe Covers Covidien 2100/cs

24456 Thermoscan® Sure Temp® Plus 690 Welch Allyn 1/ea

25572 Thermoscan® Sure Temp® Probe Covers Welch Allyn 800/bx

43632 Thermoscan® Probe Covers Welch Allyn 200/bx

Tape

14137 DuraporeTM Tape 1" x 10 yards (cloth/silk) 3M 12/rolls

14138 DuraporeTM Tape 2" x 10 yards (cloth/silk) 3M 6/rolls

33234 DuraporeTM/Single Use 1" x 1.5 yards (cloth/silk) 3M 100/rolls

32338 Hypo-Pore Tape 1" x 10 yards (paper) Dukal 12/rolls

32577 Hypo-Silk Cloth Tape 1" x 10 yards Dukal 12/rolls

19140 MicroporeTM Tape 1" x 10 yards (paper) 3M 12/rolls

32535 MicroporeTM/Single Use 1" x 1.5 yards (paper) 3M 100/rolls

32536 TransporeTM Tape 1" x 1.5 yards (clear plastic) 3M 500/rolls

14151 TransporeTM Tape 1" x 10 yards (clear plastic) 3M 12/rolls

ASD Healthcare | 33

Medical / SurgicalMSASD # DESCRIPTION MANUFACTURER PK/CS

Bandages

34440 Bandage Strip 1" x 3" (plastic) Dukal 100/bx

32553 Bandage Strip 3/4" x 3" (plastic) Dukal 100/bx

19216 Bandage Flex Strip 1" x 3" Dynarex 100/bx

19204 Bandage Sheer Strip 1" x 3" Dynarex 100/bx

32594 Gauze 2" x 2" (non-sterile) 8 Ply Dukal 5000/cs

32595 Gauze Pads 2" x 2" 8 Ply (sterile) 2's Dukal 1500/cs

32597 Gauze 4" x 4" 12 ply N/S 2000/cs Dukal 2000/cs

32693 Gauze 4" x 4" 12 ply (sterile) Dukal 100/bx

32796 Gauze 4" x 4" 8 Ply (sterile) 2's Dukal 1200/bx

24274 Gauze 2" x 2" 8 Ply (sterile) 2's Dynarex 100/bx

32578 Tegaderm 2 3/8" x 2 3/4" (compare to 3M brand) Dukal 100/bx

32741 Tegaderm 4" x 4 3/4" (compare to 3M brand) Dukal 50/bx

14163 Tegaderm™ 2 3/8" x 2 3/4" 3M brand 3M 100/bx

40159 Tegaderm™ 3 1/2" x 4 1/2" 3M Brand 3M 100/bx

18528 Tegaderm™ 4" x 4 3/4" 3M brand 3M 50/bx

13275 TelfaTM Pads Sterile 2" x 3" Covidien 100/bx

32743 Topper Sponge Sterile 4" x 3" Dukal 50/bx

32357 Zorband™ (Large) 1" x 2 3/4" (compare to Sureseal) Exel 100/bx

32358 Zorband™ (XL) 1 1/4" x 2 3/4" (compare to Sureseal) Exel 100/bx

Face Masks and Shields

34204 Face Shield (full length no visor) Precept 1/ea

18534 Mask – blue (ear loop) Dynarex 50/bx

14837 Mask – blue (molded) Dynarex 50/bx

18544 Mask – blue (ear loop w/Face Shield) Dynarex 50/bx

Test Strips

38945 Accuchek® Aviva Plus Strips Roche 50/bx

11265 Accuchek® Comfort Curve Control Solution Roche 1/bx

32328 Ascensia® Breeze Gluc. Blood Strips Bayer 50 strips

34128 Bicarb PH II Test Strips (100 per bottle) SerimResearch 5/btls

34124 Chlorine Test Strips (100 per bottle) SerimResearch 6/btls

21204 OneTouch® Ultra Test Strips Lifescan 100 strips

23596 OneTouch® Ultra Control Solution 4 mL Lifescan 2/vl

37537 Total Chlorine Hisense Test Kit Serim Research 1/kit

34131 Total Chlorine Hisense Refills 5 x 100 Serim Research 1/kit

34127 Peracetic Acid Reagant Strips (100 per bottle) Serim Research 6/btls

34126 Residual Peroxide Reagant Strips (100 per bottle) Serim Research 6/btls

34130 Water Hardness Reagent Strips (50 per bottle) SerimResearch 6/btls

34 | I ns ideOut



Needles

27525 Needles 18g x 1" Exel 100/bx

27558 Needles 18g x 1.5" Exel 100/bx


42271 Needles 21g x 1.5" Exel 100/bx


27678 Needles 25g x 5/8" Exel 100/bx

Duopross Syringes

32571 1cc 22g x 1 x 1.5" Renal Max Duopross 100/bx

32570 1cc 22g x 1.5" Renal Safe safety syr Duopross 100/bx

32575 3cc 21g x 1.5" Low Dead Space safety syr Duopross 100/bx

Syringes

32562 Insulin Syringe 1cc 29g x 1/2" Terumo 100/bx

32367 Safety Syringe 3cc 22g x 1" Exel 100/bx

22686 Syringe 1cc 27g x 1/2" Allergy (low dead space) Terumo 100/bx

27515 Syringe 1cc w/Luer Lock Exel 100/bx


18996 Syringe 3cc 20g x 1" w/Luer Lock Terumo 100/bx

27520 Syringe 3cc 21g x 1" w/Luer Lock Exel 100/bx

32367 Syringe 3cc 22g x 1" w/Luer Lock Exel 100/bx

11053 Syringe 3cc 23g x 1" Terumo 100/bx

11049 Syringe 3cc 25g x 5/8" Terumo 100/bx



27526 Syringe 10cc 21g x 1" Exel 100/bx

33579 Syringe 20cc w/Luer Lock Terumo 50/bx


27559 Syringe 50-60cc w/Luer Lock Exel 25/bx

27521 TB Syringe 1cc 25g x 5/8" Exel 100/bx

32352 TB Syringe 1cc 25g x 5/8" (zero dead space) Exel 100/bx

B/D – Syringes

10645 Syringe 10cc Luer Lock (BD# 309604) B/D 100/bx

10638 Syringe 10cc 21g x 1" (BD# 309642) B/D 100/bx


12791 Syringe 3cc 20g x 1.5" (BD# 309579) B/D 100/bx









12786 TB Syringe 1cc 25g x 5/8" (BD# 309626) B/D 100/bx

ASD Healthcare | 35

Medical / SurgicalMS

36 | I ns ideOut


B/D – Safety Syringes

23970 BD IntegraTM 3cc 22g x 1.5" low dead space B/D 100/bx

23969 BD IntegraTM 3cc 23g x 1" low dead space B/D 100/bx

12782 Insulin Safety Syringe 1cc 29g x 1.5" (BD# 329464) B/D 500/cs

18735 Safety Syringe 10cc Luer Lock (BD# 305559) B/D 50/bx

19562 Safety Syringe 10cc 21g x 1.5" (BD# 305564) B/D 50/bx




12811 Safety Syringe 3cc 25g x 5/8" (BD# 309592) B/D 100/bx



12784 TB Safety Syringe 1cc 25g x 5/8" (BD#305554) B/D 100/bx

12785 TB Safety Syringe 1cc 27g x 1/2" (BD# 305553) B/D 100/bx

Covidien – Safety Syringes

19521 Safety Syringe 1cc Insulin 29g x 1.5" Covidien 100/bx

19519 Safety Syringe 1cc 28g x 1/2" Covidien 100/bx

19518 Safety Syringe 1cc 25g x 5/8" Covidien 100/bx

19525 Safety Syringe 3cc 20g x 1 x 1.5" Covidien 100/bx

19302 Safety Syringe 3cc 21g x 1" Covidien 100/bx


19528 Safety Syringe 3cc 22g x 1.5" Covidien 100/bx

19536 Safety Syringe 6cc 20g x 1.5" Covidien 50/bx


19531 Safety Syringe 6cc Luer Lock Covidien 50/bx


ResourceConnectionLinking pharmacists to reliable sources & patient advocacy groups

ASD Healthcare | 37

Pharmacist Web Android IOS

CDC Continuing Education for Health Professionals http://bit.ly/CDCLearn

CDC Flu Surveillance for Weekly Influenza Data http://bit.ly/FluLink

Clinical Trials for Comprehensive Investigational Studies https://clinicaltrials.gov

Clinical Trials Sponsored by National Cancer Institute http://bit.ly/CancerCTs

Expanded Access Navigator for non-FDA Approved Investigational Drugs for Patients with Fatal Diseases

http://navigator.reaganudall.org

FDA Current and Resolved Drug Shortages and Discontinuations http://bit.ly/DrugShort

FDA MedWatch Volunteer Reporting Form for Adverse Events http://bit.ly/AdverseEvent

Federal Agency Disaster Preparation » ASPR / Tracie

» CDC

» FDA

» FEMA

https://asprtracie.hhs.gov/

http://bit.ly/CDCDisaster

http://FDA.gov/emergencypreparedness

http://fema.gov

Federal Healthcare Proposed Rules, Notices, Laws and Regulations » Federal Registry http://bit.ly/HealthHumanService

Kidney Community Emergency Response http://bit.ly/ESRDhelp

Level II HCPCS J-Codes for Injectable Drugs http://bit.ly/J-Code

National Drug Code (NDC) http://bit.ly/FDANDC

Orange Book for FDA Approved Drugs with Therapeutic Equivalence Evaluations

http://bit.ly/OrBook

Patient Adocacy Web Android IOS

Alpha 1 Foundation alpha-1foundation.org

Hemophilia » Kelley

» Save One Life

kelleycom.com/projectshare

saveonelife.net

Neuropathy » Neuropathy Action Foundation neuropathyaction.org

Oncology » Family Reach

» The EVAN Foundation (pediatric neuroblastoma)

familyreach.org

theevanfoundation.org

Primary Immune Diseases » Immune Deficiency Foundation

» Jeffrey Modell Foundation

primaryimmune.org

info4pi.org

Renal » Bridge of Life bridgeoflifeinternational.org

HYPERRAB®Rabies Immune Globulin (Human)

HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all theinformation needed to use HYPERRAB® safelyand effectively. See full prescribing informationfor HYPERRAB.HYPERRAB [rabies immune globulin (human)]solution for infiltration and intramuscularinjectionInitial U.S. Approval: 1974-----------------INDICATIONS AND USAGE --------------HYPERRAB is a human rabies immune globulinindicated for postexposure prophylaxis, along withrabies vaccine, for all persons suspected ofexposure to rabies.Limitations of Use:Persons previously immunized with rabies vaccinethat have a confirmed adequate rabies antibody titershould receive only vaccine. For unvaccinated persons, the combination ofHYPERRAB and vaccine is recommended for bothbite and nonbite exposures regardless of the timeinterval between exposure and initiation of post-exposure prophylaxis.Beyond 7 days (after the first vaccine dose),HYPERRAB is not indicated since an antibodyresponse to vaccine is presumed to have occurred.------------DOSAGE AND ADMINISTRATION ----------For infiltration and intramuscular use only.Administer HYPERRAB within 7 days after thefirst dose of rabies vaccine.

-----------DOSAGE FORMS AND STRENGTHS --------300 IU/mL solution for injection supplied in 1 mLand 5 mL single-dose vials. --------------------CONTRAINDICATIONS -----------------None.-------------WARNINGS AND PRECAUTIONS ----------• Severe hypersensitivity reactions, including

anaphylaxis, may occur with HYPERRAB. Haveepinephrine available immediately to treat anyacute severe hypersensitivity reactions.

• HYPERRAB is made from human blood, it maycarry a risk of transmitting infectious agents,e.g., viruses, the variant Creutzfeldt-Jakobdisease (vCJD) agent, and, theoretically, theCreutzfeldt-Jakob disease (CJD) agent.

-------------------ADVERSE REACTIONS -----------------The most common adverse reactions in >5% ofsubjects in clinical trials were injection site pain,headache, injection site nodule, abdominal pain,diarrhea, flatulence, nasal congestion, and oropha-ryngeal pain.To report SUSPECTED ADVERSE REACTIONS,contact Grifols Therapeutics Inc. at 1-800-520-2807 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatch.-------------------DRUG INTERACTIONS -----------------• Repeated dosing after administration of rabies

vaccine may suppress the immune response tothe vaccine.

• Defer live vaccine (measles, mumps, rubella)administration for 4 months.

Grifols Therapeutics Inc.Research Triangle Park, NC 27709 USA 3047927-BSU.S. License No. 1871 Revised: 2/2018

Postexposureprophylaxis,along withrabiesvaccine, aftersuspectedexposure torabies

HYPERRAB20 IU/kg

body weightOR

0.0665mL/kg

body weight

Single dose

• Administer as soon aspossible afterexposure, preferably atthe time of the firstrabies vaccine dose.

• Infiltrate the full doseof HYPERRABthoroughly in the areaaround and into thewound(s), if anatom-ically feasible.

• Inject the remainder, ifany, intramuscularly.

ASD_HyperRAB_mech_ISI_BS.indd 2 3/26/18 11:01 AM

Indication and Usage

HYPERRAB® (rabies immune globulin [human]) is indicated for postexposure prophylaxis, along with rabies vaccine, for all persons suspected of exposure to rabies.

Limitations of Use

Persons who have been previously immunized with rabies vaccine and have a confirmed adequate rabies antibody titer should receive only vaccine.

For unvaccinated persons, the combination of HYPERRAB and vaccine is recommended for both bite and nonbite exposures regardless of the time interval between exposure and initiation of postexposure prophylaxis.

Beyond 7 days (after the first vaccine dose), HYPERRAB is not indicated since an antibody response to vaccine is presumed to have occurred.

Important Safety Information

For infiltration and intramuscular use only.

Severe hypersensitivity reactions may occur with HYPERRAB. Patients with a history of prior systemic allergic reactions to human immunoglobulin preparations are at a greater risk of developing severe hypersensitivity and anaphylactic reactions. Have epinephrine available for treatment of acute allergic symptoms, should they occur.

HYPERRAB is made from human blood and may carry a risk of transmitting infectious agents, eg, viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

The most common adverse reactions in >5% of subjects during clinical trials were injection-site pain, headache, injection-site nodule, abdominal pain, diarrhea, flatulence, nasal congestion, and oropharyngeal pain.

Do not administer repeated doses of HYPERRAB once vaccine treatment has been initiated as this could prevent the full expression of active immunity expected from the rabies vaccine.

Other antibodies in the HYPERRAB preparation may interfere with the response to live vaccines such as measles, mumps, polio, or rubella. Defer immunization with live vaccines for 4 months after HYPERRAB administration.

Please see brief summary of Prescribing Information on adjacent page or visit HyperRAB.com for full Prescribing Information.

ASD_HyperRAB_mech_ISI_BS.indd 1 3/26/18 11:01 AM

© 2018 Grifols All rights reserved March 2018 BN/HB3/0318/0007

Please see Important Safety Information and brief summary of Prescribing Information for HyperRAB on adjacent pages, or visit www.HyperRAB.com for full Prescribing Information.

The #1 prescribed human rabies immune globulin (HRIG) you’ve trusted for over 40 years is now available in a new high potency formulation

NOW APPROVED! HyperRAB® (rabies immune globulin [human]) 300 IU/mL

HyperRAB® (rabies immune globulin [human]) is indicated for postexposure prophylaxis, along with rabies vaccine, for all persons suspected of exposure to rabies.HyperRAB is made from human plasma. Products made from human plasma may contain infectious agents, such as viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent that can cause disease. There is also the possibility that unknown infectious agents may be present in such products.

the volume of medication administered in a total dose

the concentration of rabies antibodies per mL at the wound site

An animal attack is traumatic enough…

PROTECT HER FROM RABIES with the potential for fewer injections

ASD_HyperRAB_mech_backcover.indd 1 3/26/18 11:22 AM

3101 Gaylord ParkwayFrisco, Texas 75034

www.asdhealthcare.com

Documents

2019- 2020 - ASD Healthcare › AsdHealthcare › media › ...Fluzone HD and Flublok are returnable up to 20% per presentation. GSK: Fluarix and Flulaval are non-returnable. Product